Immunotherapy for prostate cancer: an emerging treatment modality

Urol Clin North Am. 2010 Feb;37(1):121-9, Table of Contents. doi: 10.1016/j.ucl.2009.11.001.

Abstract

This article examines prostate cancer as a target for immunotherapy and investigates active immunotherapy for prostate cancer, combining conventional therapy with active immunotherapy, immune modulators (brakes and accelerators), and monoclonal antibodies.

Publication types

  • Review

MeSH terms

  • Drug Therapy, Combination*
  • Humans
  • Immunotherapy*
  • Male
  • Prostatic Neoplasms / immunology*
  • Prostatic Neoplasms / therapy*
  • Treatment Outcome